News | December 05, 2023
Cupid acquires land parcel near Mumbai
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
Currently, Venkat is Lead – Market Access, India at Pfizer
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Decision on EU marketing authorisation expected for momelotinib by early 2024
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Subscribe To Our Newsletter & Stay Updated
